Xrf Scientific Limited · ASX:XRF

Xrf Scientific — Investor Presentation (February 2026)

19 slides from Xrf Scientific's investor presentation, Feb 18, 2026

  1. Slide 1: Investor Presentation February 2026

    Investor Presentation February 2026

  2. Slide 2: Our Technology

    Our Technology Sample Preparation Technology Mining and Manufacturing Chemical Analysis Raw Prepared Samples Samples Minerals: Materials: Iron ore Cement Analysis Techniques: Gold Steel XRF Nickel Glass ICP Copper Ceramics Fire Assay Aluminium Research Photon Assay Bauxite Education Manganese Uraniu

  3. Slide 3: Lab Products: Orbis Sample Preparation Products

    Lab Products Orbis Sample Preparation Products For mineral analysis labs (XRF, ICP, Fire Assay, Photon Assay) Sample Weighing Station Samples are weighed and the final sample weight is entered into the PLC Laboratory Crusher Samples crushed from size of up to 110mm down to <2mm Laboratory Jaw Smart

  4. Slide 4: Lab Products: Sample Preparation Products

    Lab Products Sample Preparation Products For mineral and material analysis labs (XRF, ICP) Platinum Labware X-Ray Flux Recycling service of turning used platinum products into new items Fusion Machines 4

  5. Slide 5: Lab Products: XRTGA 1100 Thermogravimetric Analyser

    Lab Products Analytical Instruments XRTGA 1100 Thermogravimetric Analyser Used for thermal analysis of moisture, volatiles, ash, fixed carbon or loss on ignition Used in existing mining / construction material industries and new markets such as production quality control of food, plastics and agricu

  6. Slide 6: Lab Products: CS-1232 Carbon Sulphur Analyser

    Lab Products Analytical Instruments CS-1232 Carbon Sulphur Analyser Used for elemental analysis of carbon and sulphur in samples. Testing application examples: • Mining: gold, copper, bauxite, graphite • Thermal and coking coal (mining, power plants, steel plants) • Cement plants • Agricultural soil

  7. Slide 7: Lab Products: AS Series pH Conductivity Robots

    Lab Products Analytical Instruments AS Series Ph Conductivity Robots Used for pH and electrical conductivity testing in liquid and solid samples. Testing application examples: • Soil and environmental • Beverages (beer, wine) • Drinking water • Water purification processes • Waste water treatment pl

  8. Slide 8: Laboratory Products Flowchart

    Laboratory Products Flowchart XRF Analysis Elemental analysis of: Iron ore Base metals Rare earths Dose flux into platinum Fuse crucible contents Analyse prepared Mineral sands crucible, add sample into solid glass bead sample with XRF Cement spectrometer* Steel Carbon Sulphur Analysis Carbon or Sul

  9. Slide 9: FY26 H1 Highlights

    FY26 H1 Highlights  Strong demand from mining and industrial customers  International sales continuing to grow. Acceleration expected through initiatives such as new office in India  Improved demand for capital equipment products. Strong momentum for Orbis lab crushers, driven by the gold sector

  10. Slide 10: FY26 H1 Financial Highlights

    FY26 H1 Financial Highlights 31,492 30,748 31,300 28,170 28,624 28,700 27,091 21,474  Revenue up 9% to $31.3m vs 1H25 18,535  NPBT up 8% to $7.5m vs 1H25  NPAT up 5% to $5.3m vs 1H25  Operating cash inflow up 44% to $6.4m vs 1H25 1H22 2H22 1H23 2H23 1H24 2H24 1H25 2H25 1H26 Revenue ($'000)  Qua

  11. Slide 11: Balance Sheet

    Balance Sheet ($m) 1H26 2H25 Change  Net cash position of $11.0m Cash and cash equivalents 12.1 12.2 (1%)  Platinum loans repaid via a metal return due Trade and other receivables 9.0 10.3 (13%) to current high interest rates. Corresponding Inventories 17.9 18.8 (5%) $0.7m reduction in Inventories

  12. Slide 12: Cash Flow Statements

    Cash Flow Statements ($m) 1H26 2H25 1H25 Net cash inflow from operating activities 6.4 5.7 4.4 Net cash (outflow) from investing activities (1.1) (0.7) (1.5) Net cash (outflow) from financing activities (5.5) (0.9) (6.8) Cash at start of period 12.2 8.1 12.0 Net increase/(decrease) in cash (0.1) 4.1

  13. Slide 13: Consumables

    Consumables Laboratory consumables and chemicals ($m) 1H26 2H25 1H25  Overview for 1H26: Sales revenue 8.4 9.6 9.6  Revenue down 12% on 1H25 Change in % * (13%) 0% 4%  NPBT down 17% on 1H25  Continued robust demand from the mining sector. Asia NPBT 3.0 3.6 3.6 continues as a key growth market Ch

  14. Slide 14: Precious Metals

    Precious Metals Platinum laboratory and industrial products ($m) 1H26 2H25 1H25  Overview for 1H26: Sales revenue 12.6 11.2 10.3  Revenue** up 22% on 1H25 Change in % * 13% 8% (7%)  NPBT up 49% on 1H25  Continued strong demand for recycling sales. Margins NPBT 2.5 1.8 1.7 expanded, which was dri

  15. Slide 15: Capital Equipment

    Capital Equipment Laboratory instruments and machines ($m) 1H26 2H25 1H25  Overview for 1H26: Sales revenue 12.1 12.5 10.1  Revenue up 20% on 1H25 Change in % * (3%) 23% (17%)  NPBT up 24% on 1H25  Orbis generated NPBT of $819k (1H25: $697k) with sales NPBT 2.2 2.3 1.8 primarily driven by the go

  16. Slide 16: Growth Strategy for FY26

     Ramp-up sales of xrTGA  Grow Orbis laboratory crusher sales in mining markets globally  Increase Labfit product sales, leveraging our global sales Growth Strategy network for FY26  Continue with geographical expansion initiatives  New product releases:  Next generation product upgrades  Diff

  17. Slide 17: Corporate Overview

    Corporate Overview Dividends Shareholder Wealth EBIT Earnings Per Declared Per Share Price Market Share Capitalisation Share Financial Year $ Cents Cents $ $ 2019/20 4,602,319 2.3 1.4 0.24 32,118,193 2020/21 6,818,111 3.8 2.0 0.47 63,916,519 2021/22 8,259,768 4.5 2.5 0.57 77,458,468 2022/23 11,924,8

  18. Slide 18: Contact Information

    Contact Information Tel: (08) 9244 0600 86 Guthrie Street, Osborne Park WA Vance Stazzonelli – CEO vance@xrfscientific.com 18

  19. Slide 19: Disclaimer

    Disclaimer No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonableness of this Investor

XRF Scientific — Investor Presentation (February 2026) on 6ix